TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35306161

Group type: EXPERIMENTAL
Intervention: Local Infiltration Analgesia (LIA)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Fascia Iliaca Compartment Block (FICB)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Spinal Anesthesia (Control Group)
Number of subjects: 152
Study: 33819062

Group type: EXPERIMENTAL
Intervention: High-dose omega-3 fatty acids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 0
Study: 35049137

Group type: EXPERIMENTAL
Intervention: Early continuous blood purification (CBP)
Number of subjects: 130
Study: 34648009

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (loading dose of 0.5 μg/kg over 15 minutes followed by a maintenance dose of 0.2 μg/kg per hour)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 675

Group type: COMPARATOR
Intervention: Placebo infusion (normal saline)
Number of subjects: 675

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 675
Study: 35297655

Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 441

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study: 34527811

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 60
Study: 32511775

Group type: EXPERIMENTAL
Intervention: Probiotic L. reuteri lozenges
Number of subjects: 447

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 447
Study: 35268094

Group type: EXPERIMENTAL
Intervention: Medium-Chain Triglycerides (MCTs) - 2 g daily for two weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Canola oil (placebo control)
Number of subjects: 0
Study: 34378693

Group type: EXPERIMENTAL
Intervention: SHAHRP program
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 348
Study: 33681130

Group type: EXPERIMENTAL
Intervention: Fall detection device usage
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Fall detection device features
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Prevalence of falls
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Association of falls with instability
Number of subjects: 336
Study: 35536382

Group type: EXPERIMENTAL
Intervention: Celery seed extract (1.34 g extract per day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 51
Study: 33410758

Group type: EXPERIMENTAL
Intervention: Be Prepared mHealth app
Number of subjects: 86

Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 86
Study: 35077657

Group type: EXPERIMENTAL
Intervention: Háblame Bebé mobile application
Number of subjects: 37

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 37
Study: 34155075

Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home (FECH+) programme, which includes structured support and problem-solving for caregivers, delivered by a registered nurse through six 30-45 min telephone support sessions over 6 months.
Number of subjects: 925

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home (FECH+) programme
Number of subjects: 925
Study: 33147217

Group type: EXPERIMENTAL
Intervention: Dry decontamination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wet decontamination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined dry and wet decontamination
Number of subjects: 0

Group type: COMPARATOR
Intervention: No decontamination (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All decontamination protocols
Number of subjects: 0
Study: 35723044

Group type: EXPERIMENTAL
Intervention: Couple-centered counseling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 33836690

Group type: EXPERIMENTAL
Intervention: Expedited delivery recommended in women with low CPR (open arm)
Number of subjects: 2160

Group type: COMPARATOR
Intervention: Routine clinical care (concealed arm)
Number of subjects: 2160
Study: 32950029

Group type: EXPERIMENTAL
Intervention: Duke score
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Apfel score
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Non-smoking during pregnancy
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: History of postoperative nausea/vomiting after cesarean delivery and/or morning sickness
Number of subjects: 260
Study: 35301662

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Combined model
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Rad_score
Number of subjects: 109
Study: 32588036

Group type: EXPERIMENTAL
Intervention: XGBoost classifier
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) classifier
Number of subjects: 1407
Study: 32843874

Group type: EXPERIMENTAL
Intervention: Clinical evidence technology (CET) - VisualDx; usage frequency not specified.
Number of subjects: 0
Study: 36400394

Group type: EXPERIMENTAL
Intervention: Postoperative questionnaires including preoperative answers (Intervention group)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Postoperative questionnaires without preoperative answers (Control group)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Postoperative questionnaires including preoperative answers (Intervention group) for cervical spine patients
Number of subjects: 236

Group type: COMPARATOR
Intervention: Postoperative questionnaires without preoperative answers (Control group) for cervical spine patients
Number of subjects: 236
Study: 32365242

Group type: EXPERIMENTAL
Intervention: Calcipotriol/betamethasone dipropionate foam (Cal/BD foam)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Clobetasol cream
Number of subjects: 36
Study: 35110003

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) - single dose of aluminum gallium arsenide (GaAlAs) laser irradiation (808 nm; 350 milliwatts; 3.5 joule/point) with placebo medication.
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Paracetamol–caffeine tablets (3 times daily for the first couple of days after separator insertion, and as needed for the rest of the week) with placebo LED light.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo procedures (control group).
Number of subjects: 54
Study: 32476089

Group type: EXPERIMENTAL
Intervention: Simple Oral Exercise (SOE)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Chewing Gum Exercise (GOE)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: SOE
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: GOE
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study: 34512931

Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride injection combined with dexmedetomidine
Number of subjects: 93

Group type: COMPARATOR
Intervention: Oxycodone hydrochloride injection
Number of subjects: 93
Study: 32213537

Group type: EXPERIMENTAL
Intervention: Anamorelin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 36206793

Group type: EXPERIMENTAL
Intervention: Antibiotic review kit intervention
Number of subjects: 7160421
Study: 33401532

Group type: EXPERIMENTAL
Intervention: Plyometric and eccentric exercises without external loads
Number of subjects: 17

Group type: COMPARATOR
Intervention: Eccentric exercises without external loads (Control)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 17
Study: 32351183

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) treatment with a high level of CBD to low level of THC ratio
Number of subjects: 0

Group type: COMPARATOR
Intervention: No pharmacological treatment
Number of subjects: 0
Study: 34741653

Group type: EXPERIMENTAL
Intervention: Live online group resistance training
Number of subjects: 94

Group type: COMPARATOR
Intervention: In-person group resistance training
Number of subjects: 94
Study: 34118059

Group type: EXPERIMENTAL
Intervention: 1000 IU/day vitamin D3
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D3
Number of subjects: 688

Group type: COMPARATOR
Intervention: ≥1000 IU/day vitamin D3 (pooled higher doses)
Number of subjects: 688

Group type: COMPARATOR
Intervention: 200 IU/day (control)
Number of subjects: 688
Study: 32316978

Group type: EXPERIMENTAL
Intervention: Autologous dendritic cell vaccines (DCV)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Autologous tumor cell vaccines (TCV)
Number of subjects: 110
Study: 34080492

Group type: EXPERIMENTAL
Intervention: Narrative Episodic Future Thinking (EFT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Traditional Episodic Future Thinking (EFT)
Number of subjects: 160
Study: 32771041

Group type: EXPERIMENTAL
Intervention: Middle-frequency self-weighing (3-4 times/week) in the intervention arm
Number of subjects: 2607

Group type: EXPERIMENTAL
Intervention: High-frequency self-weighing (5-7 times/week) in the intervention arm
Number of subjects: 2607

Group type: COMPARATOR
Intervention: High-frequency self-weighing (5-7 times/week) in the control arm
Number of subjects: 2607
Study: 35314767

Group type: EXPERIMENTAL
Intervention: HGS-GLIM malnutrition
Number of subjects: 1359

Group type: EXPERIMENTAL
Intervention: SMI-GLIM malnutrition
Number of subjects: 1359
Study: 34848737

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 70

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 70
Study: 32069288

Group type: EXPERIMENTAL
Intervention: Digitally enabled rehabilitation using devices (virtual reality video games, activity monitors, handheld computer devices) prescribed by a physiotherapist for 6 months in hospital and at home.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group received usual multidisciplinary inpatient and post-hospital rehabilitation care without additional digital devices.
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Secondary mobility outcomes and self-reported balance confidence and quality of life measures.
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Adverse events in the intervention group.
Number of subjects: 300
Study: 34644357

Group type: EXPERIMENTAL
Intervention: Physical and cognitive training (PTCT)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Physical training (PT)
Number of subjects: 314
Study: 32905968

Group type: EXPERIMENTAL
Intervention: Training on roles and rights of HFCs
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Training and information about HF performance using PBF indicators
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Previous training of HFCs before the interventions
Number of subjects: 251
Study: 36084360

Group type: EXPERIMENTAL
Intervention: Carbohydrate Quality Index (CQI) improvement (3-point increment)
Number of subjects: 1476
Study: 34393499

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Senna plus ispaghula husk
Number of subjects: 22
Study: 35060398

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT) for postpartum depression delivered by public health nurses plus treatment as usual (TAU)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group (TAU alone)
Number of subjects: 141
Study: 32668039

Group type: EXPERIMENTAL
Intervention: 6-week web-based distance education program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 35701773

Group type: EXPERIMENTAL
Intervention: Cinnamaldehyde mucoadhesive patches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo mucoadhesive patches
Number of subjects: 0
Study: 32184277

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo-containing aluminium adjuvant (AAHS)
Number of subjects: 5
Study: 35896943

Group type: EXPERIMENTAL
Intervention: Viloxazine ER (200–600 mg/day)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study: 34286884

Group type: EXPERIMENTAL
Intervention: DUAL-TASK+AOT-MI group (action observation training–motor imagery)
Number of subjects: 25

Group type: COMPARATOR
Intervention: DUAL-TASK group (dual-task training alone)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: DUAL-TASK+AOT-MI group
Number of subjects: 25

Group type: COMPARATOR
Intervention: DUAL-TASK group
Number of subjects: 25
Study: 32172522

Group type: EXPERIMENTAL
Intervention: Vitamin D (one‐time oral dose of 120,000 IU)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (8 mg of saccharide)
Number of subjects: 35
Study: 33455975

Group type: EXPERIMENTAL
Intervention: Japan Diet (JD)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Partial Japan Diet (PJD)
Number of subjects: 98
Study: 33992280

Group type: EXPERIMENTAL
Intervention: IASTM + conventional treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 30
Study: 35378948

Group type: EXPERIMENTAL
Intervention: Bushen Huoxue method combined with platelet-rich plasma (PRP)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Platelet-rich plasma (PRP) alone
Number of subjects: 64
Study: 34535608

Group type: EXPERIMENTAL
Intervention: Stroke Riskometer™ app and informational leaflets
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard management including information leaflets only
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Stroke Riskometer™ app
Number of subjects: 132
Study: 36036379

Group type: EXPERIMENTAL
Intervention: Unilateral Non-Dominant Lower Limb Training (UNDLT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Unilateral Dominant Lower Limb Training (UDLT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 34970214

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (rTMS) at 10 Hz for 7 consecutive days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60
Study: 35468660

Group type: EXPERIMENTAL
Intervention: Patients with ED (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n=30)
Number of subjects: 60
Study: 33873029

Group type: EXPERIMENTAL
Intervention: Urinary NMRT/F
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Urinary NMRF/F
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Urinary NMRT/T
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Nicotine clearance
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Controlling for cotinine glucuronidation
Number of subjects: 768
Study: 36339187

Group type: EXPERIMENTAL
Intervention: Web-based continuum of care intervention model including management teams, health knowledge delivery, health intervention records, supervision, home visiting, and psychological guidance.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine distribution of health education materials and health education through health-themed lectures.
Number of subjects: 80
Study: 33793027

Group type: EXPERIMENTAL
Intervention: E + MOD + RS + horizontal zirconia post (ZP)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: E + MOD + RS
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: E + MOD
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sound single-rooted
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sound double-rooted
Number of subjects: 64
Study: 32034581

Group type: EXPERIMENTAL
Intervention: Dual HER2 blockade arm
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single blockade arm
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SLNB after NAT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SLNB
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SLNB with 1 SLN detected
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SLNB with 2 SLNs detected
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SLNB with more than 2 SLNs detected
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SLNB with more than 1 SLN and clipped nodes removed simultaneously
Number of subjects: 80
Study: 35975719

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Autologous Blood Injection (ABI)
Number of subjects: 60
Study: 33112273

Group type: EXPERIMENTAL
Intervention: Thyroid thermal ablation
Number of subjects: 450

Group type: COMPARATOR
Intervention: Conventional thyroidectomy
Number of subjects: 450
Study: 35605163

Group type: EXPERIMENTAL
Intervention: C3RT intervention
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard practice
Number of subjects: 146
Study: 33581683

Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Stretching exercise
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise
Number of subjects: 60
Study: 32601710

Group type: EXPERIMENTAL
Intervention: Intermittent Theta Burst Stimulation (iTBS) - 20 bilateral treatments (1 session per day, 5 days per week over a 4-week period)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intermittent Theta Burst Stimulation (iTBS)
Number of subjects: 8
Study: 35058263

Group type: EXPERIMENTAL
Intervention: True somatic acupressure (SA) intervention for 7 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham somatic acupressure (light acupressure at non-acupoints)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual care (education booklet regarding FSD symptom cluster management)
Number of subjects: 51
Study: 34496450

Group type: EXPERIMENTAL
Intervention: Garlic supplementation (800 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 80
Study: 36307830

Group type: EXPERIMENTAL
Intervention: Intervention app (mHealth tool addressing logistical and motivational barriers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention app (mHealth tool)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control app (providing general pediatric health information)
Number of subjects: 0
Study: 34151413

Group type: EXPERIMENTAL
Intervention: Doravirine 100 mg QD for 5 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Islatravir 2.25 mg QD for 14 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Coadministration of islatravir 2.25 mg and doravirine 100 mg QD for 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo QD for 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo QD for 14 days
Number of subjects: 20
Study: 32063509

Group type: EXPERIMENTAL
Intervention: Pitching distance of 18.44 m
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pitching distance of 19.05 m
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pitching distance of 19.41 m
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: All pitching distances (18.44 m, 19.05 m, 19.41 m)
Number of subjects: 26
Study: 35716442

Group type: EXPERIMENTAL
Intervention: WriteForIBD (4-day, 30-min writing program adapted for IBD)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Active control (writing about trivial topics)
Number of subjects: 19
Study: 33283731

Group type: EXPERIMENTAL
Intervention: Decitabine combined with low-dose CEG regimen (DCEG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Decitabine combined with low-dose CAG regimen (DCAG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Decitabine combined with low-dose CEG regimen (DCEG) and Decitabine combined with low-dose CAG regimen (DCAG)
Number of subjects: 45
Study: 33706000

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Cyanoacrylate closure (CAC)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Group I (GSV length ablated ≥34 cm)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Group II (GSV length ablated <34 cm)
Number of subjects: 242

Group type: COMPARATOR
Intervention: GSV diameter <5.5 mm
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: GSV diameter ≥5.5 mm
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 242
Study: 33272223

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 477

Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 477
Study: 33883816

Group type: EXPERIMENTAL
Intervention: Injectable meloxicam (n = 136)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control (saline; n = 135)
Number of subjects: 271
Study: 32940569

Group type: EXPERIMENTAL
Intervention: Tomotherapy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Conventional Radiotherapy (CR)
Number of subjects: 8
Study: 34261600

Group type: EXPERIMENTAL
Intervention: Ghamz therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 80
Study: 36376852

Group type: EXPERIMENTAL
Intervention: Supraglottic jet oxygenation and ventilation (SJOV)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Nasal cannula
Number of subjects: 72
Study: 33852758

Group type: EXPERIMENTAL
Intervention: Gelato APF Gel
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Remin Pro
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Tooth Mousse
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: MI Paste Plus
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Curodont Protect
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no remineralization)
Number of subjects: 96
Study: 36449768

Group type: EXPERIMENTAL
Intervention: Postcontrast T1 vibe images
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: T2 fast spin echo
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Precontrast T1 vibe
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: T2 turbo inversion recovery magnitude sequence
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Detection capability ratios
Number of subjects: 194
Study: 33236169

Group type: EXPERIMENTAL
Intervention: Driving Simulator tasks at BAC level 0.05%
Number of subjects: 46

Group type: COMPARATOR
Intervention: Driving Simulator tasks at BAC level 0
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Driving Simulator tasks at BAC levels 0.025% and 0.09%
Number of subjects: 46
Study: 35567549

Group type: EXPERIMENTAL
Intervention: Twitter promotion of articles
Number of subjects: 694

Group type: COMPARATOR
Intervention: Control arm (no active tweeting)
Number of subjects: 694
Study: 32641236

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 400

Group type: COMPARATOR
Intervention: Apixaban
Number of subjects: 400